Evidence map›Paper›PMID 26212931›Full record

ArticleJournal of cellular biochemistry2016

Mesenchymal Stem Cells Respond to Hypoxia by Increasing Diacylglycerols.

Kinga Lakatos, Stefanos Kalomoiris, Béla Merkely, Jan A Nolta, Fernando A Fierro

Open access · greenAbstract read
In one paragraph

Article in Journal of cellular biochemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Kinga LakatosHeart and Vascular Center, Semmelweis University, Budapest, Hungary.
Stefanos KalomoirisInstitute for Regenerative Cures, University of California Davis, Sacramento, California.
Béla MerkelyHeart and Vascular Center, Semmelweis University, Budapest, Hungary.
Jan A NoltaInstitute for Regenerative Cures, University of California Davis, Sacramento, California.
Fernando A FierroInstitute for Regenerative Cures, University of California Davis, Sacramento, California.
California Institute for Regenerative Medicine · USSemmelweis University · HUUniversity of California, Davis · US

Funding

MSCs engineered to produce Brain-Derived Neurotrophic Factor for the Treatment of Huntington's diseaseR01NS102486 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Kyle Fink, Jan A. Nolta · 2017 to 2026
$3.7M
Direct cell to cell transfer of microRNA for tissue repairR01GM099688 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI NOLTA, JAN A. · 2011 to 2015
$2.7M
Functional dissection of human A-MSC vs BM-MSC phenotypeR01HL073256 · NHLBI · WASHINGTON UNIVERSITY · PI NOLTA, JAN A. · 2003 to 2010
$2.3M
Shared LSRII Cytometer Equipment Application - UC Davis Stem Cell ProgramS10RR026825 · NCRR · UNIVERSITY OF CALIFORNIA AT DAVIS · PI NOLTA, JAN A. · 2010 to 2010
$500k
NCRR NIH HHS S10 RR026825NHLBI NIH HHS R01 HL073256NIGMS NIH HHS 1R01GM099688NIGMS NIH HHS R01 GM099688NINDS NIH HHS R01 NS102486
6 · The paper itself

Abstract

Mesenchymal stem cells (MSC) are currently being tested clinically for a plethora of conditions, with most approaches relying on the secretion of paracrine signals by MSC to modulate the immune system, promote wound healing, and induce angiogenesis. Hypoxia has been shown to affect MSC proliferation, differentiation, survival and secretory profile. Here, we investigate changes in the lipid composition of human bone marrow-derived MSC after exposure to hypoxia. Using mass spectrometry, we compared the lipid profiles of MSC derived from five different donors, cultured for two days in either normoxia (control) or hypoxia (1% oxygen). Hypoxia induced a significant increase of total triglycerides, fatty acids and diacylglycerols (DG). Remarkably, reduction of DG levels using the phosphatidylcholine-specific phospholipase C inhibitor D609 inhibited the secretion of VEGF and Angiopoietin-2, but increased the secretion of interleukin-8, without affecting significantly their respective mRNA levels. Functionally, incubation of MSC in hypoxia with D609 inhibited the potential of the cells to promote migration of human endothelial cells in a wound/scratch assay. Hence, we show that hypoxia induces in MSC an increase of DG that may affect the angiogenic potential of these cells.

Indexed as

Angiogenic ProteinsCell HypoxiaCell MovementCells, CulturedDiglyceridesEndothelial CellsHumansLipid MetabolismMesenchymal Stem CellsNeovascularization, PhysiologicAngiogenic ProteinsDiglyceridesDIACYLGLYCEROLSHYPOXIAMESENCHYMAL STEM CELLS

Identifiers

PMID26212931
PMCPMC10695329
OpenAlexW1822974301

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.